Engage an experienced and cross-functional team able to be fully operational within days.
Employ a holistic approach spanning strategy through execution.
Scale your commercial organization while simultaneously working to prepare the market.
Mitigate risk associated with a suboptimal launch.
Our Operational Philosophy.
ReCiPe™ is designed to rapidly accelerate commercialization for clinical-stage biotech companies through the creation of strategic efficiencies and excellence in execution. Utilizing an integrated approach beginning with evidence-based insights through to strategy development and implementation, ReCiPe™ can be applied from phase II to phase III of clinical development.
"Efficiency and results are the natural
outcome of expertise and practical
Christina Ansted, MPH, CCMEP
Chief Executive Officer
- Rare Disease and Gene Therapy
- Unbiased Commercial Viability
- Pre-Clinical - Phase III
- Commercial Development
- Valuation for Potential Investors
- Commercial Operations
- Strategic Market Preparation
- Market and Patient Access
- Payer Value Story Development
- Patient Services
- KOL/Key Investigator Development
- Patient Identification/Diagnostics
- Market Analytics
- Vendor Management
- Stakeholder Engagement
- Patient Journey